Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Chen

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|November 27, 2021
Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical PracticeEue-Keun Choi, Wei-Shiang Lin, Gyo-Seung Hwang, et al.
Journal of Clinical Medicine|March 11, 2023
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF ProgramTze-Fan Chao, Martin Unverdorben, Paulus Kirchhof, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2026
Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use ComparisonAngel Valladares, Joseph Imperato, Sidharth Gupta, et al.
Pediatric Research|April 19, 2017
Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNAConnie Duong, Sakiko Yoshida, Cathy Chen, et al.
Clinical Cardiology|February 27, 2025
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF ProgramRaffaele De Caterina, Martin Unverdorben, Cathy Chen, et al.
The Journal of Urology|August 21, 2012
Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney diseaseMohammed Haseebuddin, Youssef S Tanagho, Melissa Millar, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 30, 2019
MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastomaSakiko Yoshida, Connie Duong, Michael Oestergaard, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 21, 2015
The metabolism and disposition of GSK2140944 in healthy human subjectsKitaw Negash, Clara Andonian, Clive Felgate, et al.
JACC. Clinical Electrophysiology|April 26, 2023
Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure PhenotypesRiccardo M Inciardi, Robert P Giugliano, Jeong-Gun Park, et al.
JACC. Advances|November 20, 2025
Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients With Atrial Fibrillation Post-Transcatheter Aortic Valve ReplacementNicolas M Van Mieghem, Cathy Chen, Christian Hengstenberg, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|November 27, 2021
Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical PracticeEue-Keun Choi, Wei-Shiang Lin, Gyo-Seung Hwang, et al.
Journal of Clinical Medicine|March 11, 2023
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF ProgramTze-Fan Chao, Martin Unverdorben, Paulus Kirchhof, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2026
Edoxaban versus Apixaban Outcomes Differences in 8,444 Patients with Atrial Fibrillation from Italy: A Real-World Use ComparisonAngel Valladares, Joseph Imperato, Sidharth Gupta, et al.
Pediatric Research|April 19, 2017
Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNAConnie Duong, Sakiko Yoshida, Cathy Chen, et al.
Clinical Cardiology|February 27, 2025
Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF ProgramRaffaele De Caterina, Martin Unverdorben, Cathy Chen, et al.
The Journal of Urology|August 21, 2012
Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney diseaseMohammed Haseebuddin, Youssef S Tanagho, Melissa Millar, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 30, 2019
MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastomaSakiko Yoshida, Connie Duong, Michael Oestergaard, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 21, 2015
The metabolism and disposition of GSK2140944 in healthy human subjectsKitaw Negash, Clara Andonian, Clive Felgate, et al.
JACC. Clinical Electrophysiology|April 26, 2023
Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure PhenotypesRiccardo M Inciardi, Robert P Giugliano, Jeong-Gun Park, et al.
JACC. Advances|November 20, 2025
Edoxaban Dose Adjustment and Age-Associated Outcomes in Patients With Atrial Fibrillation Post-Transcatheter Aortic Valve ReplacementNicolas M Van Mieghem, Cathy Chen, Christian Hengstenberg, et al.
Pageof 7